JGC
ARNA

J. Goldman & Co’s Arena Pharmaceuticals Inc ARNA Stock Holding History

J. Goldman & Co’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-75,071
Closed -$3.27M – 427
2018
Q2 		$3.27M Sell
75,071
-206,332
-73% -$8.87M 0.17% 168
2018
Q1 		$11.1M Buy
+281,403
New +$10.9M 0.47% 50

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

J. Goldman & Co's ARNA Position: Q3 2018 in Review

J. Goldman & Co sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2018, closing a stake of 75,071 shares — an estimated $3.27M sold.

J. Goldman & Co first reported a position in ARNA in Q1 2018 and held it in 2 quarters. The position peaked at $11.1M in Q1 2018. 160 funds tracked by Wall St. Rank hold ARNA as of Q3 2018.

  • J. Goldman & Co reported no remaining Arena Pharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
  • J. Goldman & Co sold 75,071 Arena Pharmaceuticals Inc shares in Q3 2018, an estimated $3.27M.
  • J. Goldman & Co first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 2 quarters.
  • J. Goldman & Co's Arena Pharmaceuticals Inc position peaked at $11.1M in Q1 2018.
  • 160 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2018.

Based on J. Goldman & Co's 13F filing for Q3 2018, filed 14 Nov 2018.